Pershing Square Capital Management avatar

Investment presentation · 2017-01-26

PSCM 2017 Annual Investor Presentation

Pershing Square Capital Management · Bill Ackman

Herbalife Valeant activism Concentration risk

AI summary and analysis

2017 Annual Demo Review of the Pershing portfolio and controversial investments in the post-2016 period is one of the key public sources for understanding the risks of Ackman's early concentrated activist style.

Key points

  • Data show that Pershing was still deeply affected by a few controversial positions at the time, indicating that the volatility of the concentrated activist strategy was much higher than that of the ordinary quality value portfolio.
  • Herbalife and Valeant content illustrates the complexities between short sellers' open battles, regulatory judgments, and fundamental judgments.
  • Demonstrates that ongoing disclosure of PSH structure and performance can help understand how closed-end fund discounts may amplify during periods of stress.
  • This piece of information, tied together with the 2018 presentation, is the backdrop for Ackman's transition from his old strategy to a subsequent high-quality long-term portfolio.
  • The average investor should look at this material not just for stock views, but for how high conviction, open battle, and risk control interact with each other.

Other viewpoints from the same firm

PSCM 2026 Annual Investor Presentation

The Ackman team's 2026 annual investor presentation, reviewing 2025 PSH performance, debt and discount strategies, Howard Hughes strategic trades, and public position logic for Amazon, Meta, Uber, and more.

Investment presentation

PSCM 2025 Annual Investor Presentation

2025 Annual Presentation Review 2024 PSH performance, PSCM minority sale, PSUS plan, discount management and Howard Hughes transaction background.

Investment presentation

Fannie Mae and Freddie Mac: The Art of the Deal

Pershing's presentation on Fannie Mae and Freddie Mac's exit from conservatorship, systematizing the GSE restructuring framework, capital structure and potential paths for common/preferred stock holders.

Investment presentation

PSCM 2024 Annual Investor Presentation

2024 Annual Presentation Summary 2023 portfolio and PSH structure, highlighting London listings, discounts, buybacks, debt structure and core holdings updates.

Investment presentation

PSCM 2023 Annual Investor Presentation

The 2023 annual presentation covers portfolio performance after 2022 interest rates and market stress, PSH discounts, concentrated holdings and Pershing's restatement of long-term compounding assets.

Investment presentation

PSCM 2022 Annual Investor Presentation

2022 Annual Demo Review 2021 Portfolio, SPARC/PSTH related background, long holdings, and Pershing's build on the Permanent Capital platform.

Investment presentation